Skip to main navigation Skip to main content

Digital workshop

MATOD Module 3 - Long-acting Injectable Buprenorphine Members login for free access About RACGP online events

Details

Type: Digital workshop
19 May, 2:12 PM - 29 Sep, 12:00 PM (AEST)

Contact

For more information:
Email: Hannah Lack
Call: 03 8699 0957

Price

RACGP Members: FREE
Non-Members: FREE

Free registration

MATOD Module 3 - Long-acting Injectable Buprenorphine

Digital workshop 19 May, 2:12 PM - 29 Sep, 12:00 PM (AEST)

Medication Assisted Treatment for Opioid Dependence

Module 3 - Long-acting injectable buprenorphine: Builds on knowledge of prescribing and administering long-acting injection buprenorphine, including how to select, initiate and manage patients who are using these new opioid substitutions.

Please contact MATOD Program Coordinator, Hannah Lack on 03 8699 0957 or via email at vic.MATOD@racgp.org.au if you don't have a RACGP number.

Learning outcomes

  1. Correctly interpret legislative frameworks and evidence-based clinical guidelines for the use of Long-Acting Injection Buprenorphine
  2. Describe the options available for opioid dependent people who are considering Long-Acting Injection Buprenorphine
  3. Apply pharmaceutical knowledge and rationale to the prescribing principles for Long-Acting Injection Buprenorphine
This event attracts 4 CPD points

This event attracts 4 CPD points

This event is part of Medication Assisted Treatment for Opioid Dependence. Events in this series are:

Advertising

© 2022 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807